Fourth Dose of Human Papillomavirus (HPV) DNA Plasmid (VGX-3100) + EP in Adult Females Previously Vaccinated With Three Doses of VGX-3100

Clinical trial NCT01188850 · COMPLETED

Trial details

NCT number: NCT01188850
Sponsor: Inovio Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Human Papillomavirus (HPV)

Start date: 2010-07-01
Primary completion: 2011-10-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.